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Abstract
Background: In Korea, the cutoff values of waist circumference (WC) for the identification of
metabolic syndrome (MetS) were suggested to be 90 cm for men and 85 cm for women based on
the analysis mainly in middle-aged adults. As aging is associated with increased fat, especially
abdominal visceral fat, the cutoff value of WC may differ according to age. In addition, the
usefulness of visceral abdominal fat area (VFA) to predict MetS in the elderly has not been studied
yet. We aimed to suggest WC and VFA criteria and to compare the predictability of WC and VFA
to identify people at risk for MetS.
Methods: A total of 689 elderly subjects aged ≥63 years (308 men, 381 women) were chosen in
this cross-sectional study from an ongoing, prospective, population-based study, the Ansan
Geriatric (AGE) cohort study. VFA was measured by single slice abdominal computed tomography
scanning. The metabolic risk factors except WC (plasma glucose, blood pressure, serum
triglycerides and HDL cholesterol levels) were defined using modified NCEP-ATP III criteria. We
estimated the accuracy of VFA and WC for identifying at least two of these factors by receiver
operating characteristic (ROC) curve analysis.
Results: Two hundred three of 308 men and 280 of 381 women had ≥2 metabolic risk factors.
The area under the ROC curve (AUC) value for VFA to predict the presence of ≥2 metabolic risk
factors was not significantly different from that for WC (men, 0.735 and 0.750; women, 0.715 and
0.682; AUC values for VFA and WC, respectively). The optimal cutoff points for VFA and WC for
predicting the presence of ≥2 metabolic risk factors were 92.6 cm2 and 86.5 cm for men and 88.9
cm2 and 86.5 cm for women.
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Conclusion: WC had comparable power with VFA to identify elderly people who are at risk for
MetS. Elderly Korean men and women had very similar cutoff points for both VFA and WC
measurements for estimating the risk of MetS. Age-specific cutoff point for WC might be
considered to identify subjects at risk for MetS.
Background
In 2006, the International Diabetes Federation proposed
that central obesity is a prerequisite for the diagnosis of
metabolic syndrome (MetS). Central obesity is defined
using ethnicity-specific cutoff point of waist circumfer-
ence (WC) [1]. The Korean Society for the Study of Obes-
ity (KOSSO) set Korean-specific WC cutoff points of 90
cm for men and 85 cm for women [2]. These numbers
were derived through analysis of data collected during the
Korean National Health and Nutrition Examination Sur-
vey (KNHANES) 1998 [3], which is a representative data
of non-institutionalized Korean civilians. However, the
KOSSO did neither provide the cutoff point for visceral
abdominal fat area (VFA) nor did differentiate WC criteria
by age group.
Normal aging process is characterized by progressive
increase in fat mass and more central distribution of adi-
pose tissue [4,5]. These changes can have important con-
sequences on the profile of risk factors for developing
MetS. Women are particularly susceptible to increase in
visceral fat as they go through menopause [6]. Consider-
ing that the accumulation of visceral fat with aging can be
more prominent in women than in men, the gender dif-
ference in current Korean-specific criteria for abdominal
obesity could be decreased with aging. Recently, a few
studies have reported that VFA and WC cutoff points for
the identification of subjects at risk for developing MetS
differ by age, with older women experiencing higher VFA
and WC cutoff points than younger women [7,8].
We estimated optimal values for VFA, WC and body mass
index (BMI) cutoff points for defining central obesity by
comparing the predictive validity of the metabolic risk fac-
tors other than WC in elderly Korean men and women in
order to verify the adequacy of the current criteria of
abdominal obesity in elderly Koreans.
Methods
Study participants
This cross-sectional study was conducted within the
framework of the Ansan Geriatric (AGE) Study. The AGE
study is an ongoing prospective population-based cohort
study including subjects who are at least 60 years old and
live in Ansan, a suburb of Seoul, Republic of Korea. A ran-
dom sample of these elderly Koreans (n = 2,767) was
assembled in 2002. The sampling protocol and design of
the AGE study has been previously reported [9]. From this
database, we constructed the 1st wave sample of the AGE
cohort study that was age- and sex-stratified [10,11].
Briefly, all subjects received a telephone call and a letter 3
times inviting them to attend a comprehensive health
screening at the Geriatric Health Clinic and Research Insti-
tute, Korea University Hospital, Ansan, Korea. After
excluding the subjects who refused to participate or who
were not reached at this invitation, a total of 1,391 sub-
jects were recruited between September 2004 and March
2006 and were regarded as the 1st wave sample. The fol-
low-up assessment (2nd wave study) was performed two
years later (25.6 ± 5.1 months) between April 2006, and
January 2008. A total of 841 subjects (2nd wave sample
set) were followed from the 1st wave sample with the same
recruitment protocol of the 1st wave sample. This study
was conducted as a cross-sectional study from the 2nd
wave sample set of the AGE Study because abdominal
computed tomography (CT) scan was taken from the 2nd
wave study. Among the 2nd wave sample set (n = 841), a
total of 152 subjects were excluded because they had
insufficient clinical data (n = 12) or no available abdomi-
nal CT scan (n = 140).
A total of 689 Korean subjects (308 men, 381 women;
mean age, 70.8 ± 5.0 years; range, 63-86 years) were ulti-
mately eligible for participation in this analysis. Written
informed consent was obtained from each individual. The
study protocol was approved by the institutional review
board of the AGE study.
Anthropometric measurements and blood tests
Anthropometric measurements for each participant were
taken after an overnight fast while the subject wore light
clothing and no shoes. Height was determined using a
fixed wall-scale measuring device and was measured to
the nearest 0.1 cm. Weight was measured to the nearest
0.1 kg using an electronic scale that was calibrated prior to
each measurement. BMI was calculated as the weight in
kilograms divided by the square of the height in meters.
The WC was measured twice to the nearest 0.5 cm in a
horizontal plane at the level of the umbilicus at the end of
normal expiration. If the variation between these two
measurements was greater than 2 cm, a third measure-
ment was taken and the mean was calculated by using the
two closest measurements. Blood pressure was measured
using a mercury sphygmomanometer (Baumanometer;
W.A.Baum, Copiague, NY) in the supine position after at
least a 10-min rest period by trained technicians. ThreeBMC Public Health 2009, 9:443 http://www.biomedcentral.com/1471-2458/9/443
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measurements were taken from all the subjects at 2-min
intervals, and the average of the last two measurements
was used. These were recorded to the nearest 2 mmHg.
Blood samples were taken in the morning after an over-
night fast. All subjects had a 75 g oral glucose tolerance
test (OGTT). We measured fasting and post two hour
OGTT-glucose levels. Plasma glucose, serum triglycerides
and HDL-cholesterol levels were measured using an auto-
analyzer (ADVIA1650; Siemens, NY, USA).
Definition of the metabolic risk factors except WC
The metabolic risk factors were defined using the modi-
fied NCEP-ATP III criteria, with the exception of WC [12]
as follows: 1) fasting plasma glucose ≥100 mg/dL or post
two hour OGTT-glucose ≥ 140 mg/dL or taking medica-
tion for previously diagnosed type 2 diabetes; 2) blood
pressure ≥ 130/85 mmHg or taking medication for previ-
ously diagnosed hypertension; 3) serum triglycerides lev-
els ≥ 150 mg/dL; 4) serum HDL cholesterol levels < 40
mg/dL in men, < 50 mg/dL in women.
Determination of visceral fat area using computed 
tomography
The abdominal adipose tissue areas were quantified by a
single slice computed tomography (CT) scan at a 120 kV
exposure (Brilliance 64; Philips, Cleveland, USA). A 5-
mm CT slice scan was acquired at the L4-L5 vertebral
interspace to measure the total abdominal and visceral
abdominal fat areas (VFA) by measuring the mean value
of all pixels within the range of -190 to -30 Hounsfield
units. The images were converted into files compatible
with a commercial software program (EBW; Philips,
Cleveland, USA). Subcutaneous abdominal fat area (SFA)
was determined by subtracting VFA from total abdominal
fat area.
10-year Framingham coronary heart disease risk score
After excluding subjects with a previous history of cardio-
vascular disease (n = 38), 10-year Framingham coronary
heart disease risk score (10-Yr FRS) was calculated as sug-
gested by D'Agostino et al., which estimates risks for cor-
onary heart disease in the next 10 years [13]. The equation
includes risk variables such as age, diagnosis of diabetes,
current smoking, categories of systolic/diastolic blood
pressure, total cholesterol and HDL cholesterol. The 10-Yr
FRS was evaluated as high risk for greater than 20%.
Statistical analysis
Continuous variables were expressed as gender-specific
means and standard deviations. Discrete variables were
expressed as gender-specific proportions. For continuous
variables, a Student's t-test was used to assess differences
in means between the groups. For categorical data, a chi-
square test was used to assess differences in proportions
across the categories.
A receiver operating characteristic (ROC) curve analysis
was used to assess the accuracy of VFA, WC, and BMI for
identifying at least two of the metabolic risk factors, or for
identifying each factor separately. ROC curve analysis for
identifying a greater than 20% 10-Yr FRS was performed
after excluding subjects with a previous history of cardio-
vascular disease (n = 38). A comparison of the diagnostic
abilities for each test was performed using the area under
the curves (AUC). The significance of the difference
between the two areas was assessed using the method
described by Hanley and McNeil [14,15]. The optimal cut-
off points were obtained from the point on the ROC curve
which was closest to (0, 1). This point was calculated as
the minimum value of the square root of [(1-sensitiv-
ity)2+(1-specificity)2] [16]. We performed a simple regres-
sion analysis to define the correlations between VFA and
WC. All reported p values were two-tailed. P-values of less
than 0.05 were considered statistically significant. Statisti-
cal analyses were conducted using SAS version 9.1 for
Windows (SAS Institute Inc., Cary, NC).
Results
Subject characteristics
Table 1 outlines the baseline characteristics of our sub-
jects. The mean age of the subjects was about 70 years of
age. The mean BMI was 24.0 kg/m2 in men and 25.0 kg/
m2 in women. Men and women had very similar mean
WCs of around 88 cm. SFA, but not VFA, was significantly
greater in women than in men. The proportion of subjects
who had two or more metabolic risk factors was 65.9% in
men and 73.5% in women. The mean age of subjects who
had two or more metabolic risk factors was not different
from those with less than one risk factor. Both men and
women with two or more metabolic risk factors were
more obese and had worse metabolic characteristics than
subjects with less than one risk factor. Women were more
likely to have reduced HDL-C levels than men. After
excluding subjects with a previous history of cardiovascu-
lar disease, the proportion of subjects with more than
20% of 10-Yr FRS was 66.4% in men and 28.7% in
women. The upper 80th percentile of VFA, WC, and BMI
was 142.7 cm2, 94 cm, and 26.2 kg/m2 for men and 145.4
cm2, 95 cm, and 27.4 kg/m2 for women.
Predictability and the cutoff points of VFA, WC, and BMI 
for identifying the presence of two or more metabolic risk 
factors, or a greater than 20% 10-Yr FRS
AUC values of VFA, WC, and BMI for identifying the pres-
ence of two or more metabolic risk factors are presented
in Table 2. In both men and women, the AUC for VFA did
not show higher values compared to WC and BMI (Table
2, Fig. 1). VFA had greater AUC values compared to WC or
BMI only in distinguishing women with hypertriglyceri-
demia or men with low HDL cholesterol levels.BMC Public Health 2009, 9:443 http://www.biomedcentral.com/1471-2458/9/443
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The optimal cutoff points of VFA for identifying the pres-
ence of two or more metabolic risk factors were 92.6 cm2
for men and 88.9 cm2 for women (Table 3). For WC, the
optimal cutoff point was the same for both men and
women (86.5 cm). This cutoff point identified 75% of
men who had increased metabolic risk, while the
KOSSO's cutoff point of 90 cm identified only 54%. For
BMI, the optimal cutoff points were 23.7 kg/m2 for men
and 23.9 kg/m2 for women. All of the cutoff points were
very similar between men and women. In addition, both
genders had similar optimal VFA and WC cutoff points for
identifying ≥20% 10-Yr FRS (VFA and WC; 102.4 cm2 and
87.0 cm in men; 105.9 cm2 and 88.7 cm in women). The
AUC for VFA did not show higher values compared to WC
Table 1: Characteristics of study subjects according to the presence of two or more metabolic risk factors except WC in elderly 
Koreans
Men Women
Total Two or more metabolic risk factors of 
the modified NCEP-ATP III of the 
criteria except WC
Total Two or more metabolic risk factors of 
the modified NCEP-ATP III of the 
criteria except WC
Absent Present Absent Present
N (%) 308 105 (34.1) 203 (65.9) 381 101 (26.5) 280 (73.5)
Age (years) 71.2 ± 5.2 70.6 ± 5.1 71.6 ± 5.3 70.5 ± 4.7 70.5 ± 5.0 70.5 ± 4.7
Body mass index (kg/
m2)
24.0 ± 2.8 22.6 ± 2.4 24.7 ± 2.7* 25.0 ± 3.1† 23.4 ± 3.4 25.6 ± 2.8*
Waist circumference 
(cm)
88.0 ± 7.6 83.9 ± 7.0 90.2 ± 7.0* 88.5 ± 8.3 84.6 ± 9.1 90.0 ± 7.5*
VFA (cm2) 103.6 ± 49.1 78.3 ± 40.4 116.7 ± 48.2* 108.9 ± 45.4 84.0 ± 37.5 117.9 ± 44.7*
SFA (cm2) 157.1 ± 50.9 138.6 ± 47.5 166.7 ± 50.1* 239.4 ± 67.8† 215.5 ± 74.9 248.0 ± 63.0*
Fasting glucose 
(mg/dl)
96.5 ± 17.0 90.0 ± 8.9 99.8 ± 19.0* 95.8 ± 21.1 88.1 ± 10.6 98.5 ± 23.1*
post 2 hr OGTT-
glucose (mg/dl)
129.5 ± 50.8 103.7 ± 34.0 145.5 ± 52.9* 138.5 ± 51.7 109.1 ± 27.2 150.9 ± 54.5
High glucose (n, (%))a 151 (49.0) 15 (14.3) 136 (67.0)* 187 (49.1) 10 (9.9) 177 (63.2)*
Taking oral 
hypoglycemic 
medication or insulin 
(n,(%))
41(13.3) 3 (2.9) 38 (18.7)* 44 (13.6) 3 (3.0) 41 (14.6)*
Systolic blood 
pressure
129.4 ± 15.6 123.2 ± 16.2 132.6 ± 14.3* 127.3 ± 16.1 120.0 ± 13.4 129.9 ± 16.2*
Diastolic blood 
pressure
76.1 ± 8.5 73.9 ± 7.5 77.3 ± 8.7* 75.2 ± 8.0 72.1 ± 8.1 76.3 ± 7.7*
High blood pressure 
(n, (%))b
205 (66.6) 35 (33.3) 170 (83.7)* 249 (65.4) 35 (34.7) 214 (76.4)*
Taking 
antihypertensive 
medication (n, (%))
140(45.5) 20 (19.1) 120 (59.2)* 185 (48.6) 21 (20.8) 164 (58.6)*
Triglycerides (mg/dl) 137.1 ± 80.9 97.9 ± 29.3 157.4 ± 91.0* 146.5 ± 80.9 92.2 ± 26.9 166.0 ± 84.9*
Hypertriglyceridemia 
(n, (%))c
96 (31.2) 5 (4.8) 91 (44.8)* 138 (36.2) 1 (1.0) 137 (48.9)*
HDL cholesterol 
(mg/dl)
41.0 ± 10.2 46.8 ± 9.4 38.1 ± 9.2* 43.1 ± 10.4† 51.6 ± 9.8 40.0 ± 8.8*
Low HDL 
cholesterol (n,(%))d
159 (51.6) 16 (15.2) 143 (70.4)* 286 (75.1)† 39 (38.6) 247 (88.2)*
Taking lipid-lowering 
medication (n, (%))
31 (10.1) 8 (7.6) 23 (11.3) 44 (11.6) 10 (9.9) 34 (12.1)
Data are mean ± S.D. or %. VFA, Visceral abdominal fat area; SFA, Subcutaneous abdominal fat area
aHigh glucose was diagnosed if fasting glucose ≥100 mg/dl or post 2 hr OGTT-glucose ≥140 mg/dl or the subjects with oral hypoglycemic 
medication or insulin.
bHigh blood pressure was diagnosed if systolic blood pressure was ≥130 mmHg, diastolic blood pressure ≥85 mmHg, or the subjects with 
antihypertensive medications.
cHypertriglyceridemia was diagnosed if triglycerides was ≥150 mg/dl in men and women.
dLow HDL cholesterol was diagnosed if HDL cholesterol was < 40 mg/dl in men and < 50 mg/dl in women.
*: p <0.01 compared with subjects without two or more metabolic risk factors in each gender.
†: p < 0.01 compared with men.BMC Public Health 2009, 9:443 http://www.biomedcentral.com/1471-2458/9/443
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for identifying ≥20% 10-Yr FRS (AUC values of VFA and
WC; 0.690 and 0.650 in men (p = 0.11); 0.642 and 0.640
in women (p = 0.96)). The optimal VFA and WC cutoff
points did not change when we excluded individuals tak-
ing oral hypoglycemic medication, insulin, or lipid-lower-
ing medication (VFA and WC; 92.6 cm2 and 86.5 cm in
men (n = 223); 88.9 cm2 and 85.5 cm in women (n =
270)).
Gender-specific WC values corresponding to VFA
When we performed the simple regression analyses
between VFA and WC, the regression lines indicated that
a VFA of 92.6 cm2 (cutoff point from the ROC analysis)
corresponded to a WC of 86.8 cm in men. In women, a
VFA of 88.9 cm2 (cutoff point from the ROC analysis) cor-
responded to a WC of 86.2 cm. Therefore, men and
women had very similar predicted values for WC based on
the cutoff points of VFA.
Prevalence of MetS using modified NCEP-ATP III criteria
When we used the modified NCEP-ATP III criteria with
KOSSO's cutoff point for abdominal obesity (≥90 cm for
men and ≥85 cm for women) [2], the prevalence of
abdominal obesity and MetS was consistently higher in
women than in men (p < 0.001 between genders, Fig 2A).
In contrast, the prevalence of abdominal obesity and MetS
using WC cutoff points suggested in this study (≥86.5 cm
for both men and women) was similar in both genders (p
> 0.05 between genders, Fig. 2B).
Discussion
We demonstrated that the optimal WC cutoff points for
predicting two or more metabolic risk factors or for iden-
tifying a greater than 20% 10-Yr FRS were same in elderly
Korean men and women. Optimal VFA and BMI cutoff
points were also similar in both genders. Given our find-
ings, WC cutoff points determined for young and middle-
aged adults may not appropriately characterize elderly
Koreans.
In 2006, KOSSO (the Korean Society for the Study of
Obesity) set WC criteria for central obesity at 90 cm for
men and 85 cm for women. These numbers are based on
the upper 80th percentile for WC values in middle-aged
Koreans [2]. In the present study, we found that the WC
cutoff point was similar in both genders when using the
Table 2: Areas under the ROC curve of VFA, WC and BMI to identify the presence of the metabolic risk factors other than WC
Men (n = 308) Women (n = 381)
ROC curve area (95% CI) P value compared with VFA ROC curve area (95% CI) P value compared with VFA
Two or more metabolic risk factors of the modified NCEP-ATP III criteria other than waist circumference
VFA 0.735 (0.676-0.794) 0.715 (0.656-0.774)
WC 0.750 (0.693-0.807) 0.509 0.682 (0.617-0.747) 0.229
BMI 0.717 (0.659-0.775) 0.512 0.684 (0.619-0.749) 0.270
Fasting glucose ≥ 100 mg/dl or post 2 hr OGTT-glucose ≥ 140 mg/dl or medication for diabetes
VFA 0.670 (0.609-0.731) 0.624 (0.568-0.680)
WC 0.684 (0.624-0.744) 0.431 0.612 (0.556-0.668) 0.687
BMI 0.637 (0.575-0.699) 0.283 0.581 (0.524-0.638) 0.100
High blood pressure a
VFA 0.653 (0.588-0.718) 0.614 (0.554-0.674)
WC 0.671 (0.609-0.733) 0.445 0.608 (0.547-0.669) 0.842
BMI 0.676 (0.613-0.739) 0.397 0.617 (0.556-0.678) 0.898
Hypertriglyceridemia b
VFA 0.647 (0.585-0.709) 0.673 (0.618-0.728)
WC 0.622 (0.555-0.689) 0.319 0.615 (0.558-0.672) 0.028
BMI 0.600 (0.532-0.668) 0.080 0.615 (0.559-0.671) 0.032
Low HDL cholesterol c
VFA 0.692 (0.633-0.751) 0.620 (0.553-0.687)
WC 0.664 (0.604-0.724) 0.235 0.597 (0.526-0.668) 0.431
BMI 0.631 (0.569-0.693) 0.018 0.585 (0.514-0.656) 0.229
VFA, visceral fat area; WC, waist circumference; BMI, body mass index
aHigh blood pressure was diagnosed if systolic blood pressure was ≥130 mmHg, diastolic blood pressure ≥85 mmHg, or the subjects was receiving 
antihypertensive medications.
bHypertriglyceridemia was diagnosed if triglycerides was ≥ 150 mg/dl in men and women.
cLow HDL cholesterol was diagnosed if HDL cholesterol was < 40 mg/dl in men and < 50 mg/dl in women.BMC Public Health 2009, 9:443 http://www.biomedcentral.com/1471-2458/9/443
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80th percentile of WC. This is because the mean WC of
men was not different from that of women. Young men
typically have a higher WC compared to women.
Although there are some ethnic differences [17,18], these
differences become smaller with age. In our elderly sub-
jects, women had similar mean WC and even slightly
higher BMI compared to men. We confirmed that the dif-
ference of mean WC between genders decreased with age
in the Third KNHANES, a nationwide survey which was
conducted in 2005 (mean WC in subjects with 20-63
years old (n = 6480), 76.3 cm in men and 72.0 cm in
women; vs. in subjects ≥63 years (n = 1069), 85.0 cm in
men and 83.2 cm in women, unpublished data). Another
study in Chinese population demonstrated the same fea-
ture. Younger Chinese men had higher mean WC and BMI
than younger Chinese women but older Chinese men had
ROC curves to identify ≥2 metabolic risk factors other than WC Figure 1
ROC curves to identify ≥2 metabolic risk factors other than WC. In both men and women, the AUC values for VFA 
did not show higher values compared to WC and BMI.
Table 3: The optimal cutoff points of VFA, WC, and BMI to detect subjects with two or more metabolic risk factors except WC 
compared to various criteria
Cut point Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
J valuea Distance
Men (n = 308)
VFA(cm2) Optimal cut point a 92.6 70.4 70.5 82.2 44.8 0.41 0.42
WC (cm) Optimal cut point a 86.5 74.9 65.7 80.9 42.5 0.41 0.43
KOSSO's cut point b 90.0 54.2 81.9 85.3 52.0 0.36 0.49
BMI (kg/m2) Optimal cut point a 23.7 63.1 70.5 80.5 50.3 0.34 0.47
WHO's cut point c 25.0 45.8 84.8 85.3 55.3 0.31 0.56
Women (n = 381)
VFA (cm2) Optimal cut point a 88.9 72.5 59.4 83.2 56.2 0.32 0.49
WC (cm) Optimal cut point a 86.5 69.3 60.4 82.9 58.5 0.30 0.50
KOSSO's cut point b 85.0 76.4 51.5 81.4 55.9 0.28 0.54
BMI (kg/m2) Optimal cut point a 23.9 72.5 58.4 82.9 56.6 0.31 0.50
WHO's cut point c 25.0 54.6 64.4 81.0 66.2 0.19 0.58
PPV, positive predictive value; NPV, negative predictive value
a : Optimal cut point from the present study for abdominal obesity
b: KOSSO's criteria for abdominal obesity [2]
c : WHO-Asia Pacific Region criteria for obesity [23]BMC Public Health 2009, 9:443 http://www.biomedcentral.com/1471-2458/9/443
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comparable or even lower mean WC and BMI than older
Chinese women [19]. When comparing the present study
and the recent publication with 816 middle-aged Korean
subjects who underwent routine health examinations
[20], appropriate VFA cutoff points for middle-aged men
in their study was comparable to those for elderly men in
this study (100 cm2 vs. 93 cm2), whereas cutoff points for
young women was lower than those for elderly women in
this study (70 cm2 vs. 89 cm2). It could be from that
women have a relatively greater increase in visceral fat
after menopause [21]. Changes in sex hormones, dietary
intake, and energy expenditure during menopause can be
related to increase in visceral fat and prevalence of obesity
in senescence [6,22]. Considering these changes in body
composition and metabolism in elderly women, the car-
diovascular risk associated with central obesity may be
different from that of younger women. Some Asian
reports have indicated that the WC cutoff points for a mid-
dle aged population are different from those of older pop-
ulation [8,19]. It should be further investigated whether
age-related changing pattern of obesity is specific to
Asians.
The prevalence of MetS in men was greater than in women
until the fifth decade in KNHANES 1998 [3], using the
definition of abdominal obesity recommended by the
WHO Western Pacific Region of WC ≥90 cm in men and
≥80 cm in women [23,24]. However, after that period,
women had a significantly higher prevalence of MetS than
men. These results may be partially explained by relatively
lower cutoff point of WC for women. When we used
higher WC cutoff point for women such as the KOSSO cri-
teria for abdominal obesity (WC ≥90 cm in men, ≥85 cm
in women), the prevalence of MetS was still higher in
women (48.1% in men and 64.3% in women). However,
it was not different according to gender with the optimal
WC cutoff points that we identified (61.0% in men and
61.4% in women). These results indicate that age-specific
WC criteria which may reflect age-associated body com-
positional change will more consistently identify high risk
subjects, especially in old age population compared to the
uniform criteria. However, this feature is not evident in
certain populations. In the Third National Health and
Nutrition Examination Survey III (NHANES III) of Amer-
ican adults, the prevalence of MetS was similar between
genders throughout all age groups despite using the same
cutoff points for central obesity in both young and old
populations [25]. This could be due to continued differ-
ences in the mean WC between men and women through-
out their entire lifespan in certain ethnics [26].
The predictability of WC for identifying the risk of MetS
was comparable to that of VFA in our study. Some studies
in Japanese subjects reported that VFA was better than WC
and BMI for identification of subjects with two or more
components of MetS [8,27]. In contrast, a Korean study in
obese middle-aged women showed that the VFA is not
superior to WC for predicting metabolic risk factors [28].
Another Japanese study has shown that VFA does not have
better correlation with carotid intima-media thickness as
The proportion of subjects with abdominal obesity and metabolic syndrome using modified NCEP-ATP III criteria with  KOSSO's WC cutoff points (≥ 90 cm for men and ≥ 85 cm for women) (A) or with our WC cutoff points (≥86.5 cm for both  men and women) (B) Figure 2
The proportion of subjects with abdominal obesity and metabolic syndrome using modified NCEP-ATP III cri-
teria with KOSSO's WC cutoff points (≥ 90 cm for men and ≥ 85 cm for women) (A) or with our WC cutoff 
points (≥86.5 cm for both men and women) (B).
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a surrogate measurement of atherosclerosis than waist-
hip-ratio or WC [29]. It should be investigated in the
future whether VFA is really superior to WC for predicting
the clustering of metabolic risk factors in general popula-
tion. Because WC is an inexpensive and clinically feasible
measurement compared to the direct imaging required for
assessing visceral fat, we suggest that WC measurements
are sufficient for the detection of central obesity in corre-
lation with the risk of MetS in elderly Koreans.
Although the present study is the first population-based
cohort report in Korea that addresses the VFA cutoff point,
it has some limitations. Firstly, we only showed the cross-
sectional association between WC, VFA and MetS. Further
investigation with prospective design is needed to clarify
more reliable cutoff points of WC and VFA, above which
the development of cardiovascular diseases increase. Sec-
ondly, we cannot provide comparative data between
young and elderly subjects to estimate different WC and
VFA criteria according to changes in body composition.
However, the present study may reliably present meta-
bolic features in elderly due to relatively large number of
elderly subjects.
Conclusion
According to both VFA and WC measurements, elderly
Korean men and women had very similar cutoff points for
the risk of MetS. WC and VFA were similarly useful for
identifying people with metabolic risk factors in elderly
Korean subjects. We propose that age-specific optimal cut-
off points for WC might be considered for identifying sub-
jects at metabolic risks.
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